GSK3B and diabetes mellitus: Previous studies have suggested that abnormal activation of GSK3β and decreased levels of p-GSK3β can depress glycogen synthesis and inhibit the insulin signaling pathway, which contributes to in the induction of insulin resistance in diabetes mellitus [49,50].